VTN and neoplasm: Many recent reports highlight the role of local dysregulation of complement proteins in the tumour microenvironment and how targeting such dysregulation can have either anti- or pro-tumouricidal effects depending on several factors including treatment scheduling, the tumour type and its microenvironment characteristics.